Bioneer A/S is an innovative research-based company with a history of more than 25 years of operation. Bioneer is a subsidiary of the Technical University of Denmark and is approved by the Danish Ministry of Higher Education and Science as an authorised provider of services with biomedicine and biotechnology. Since 2006, Bioneer has worked extensively on the development and implementation of applied stem cell technologies and stem cell focused platforms, within both multipotent and pluripotent stem cells. Bioneer has established a national iPSC core facility that operates in a variety of national and international research programs. Bioneer has been involved in several FP7 stem cell research programs, including BESTStem Cells, HEPA-TOX, STEMXpand and is currently involved in the EU programs STEMMAD and SURFSTEM.
Key staff involved in EBiSC
Christian Clausen (Head of Biomedical Technology and Chairman of Danish Stem Cell Society) – (click here for more information about Christian Clausen)
Bjørn Holst, PhD (R&D Manager, Disease Models) – He lead the operational processes of the iPSC expansion, QC and banking at the Bioneer production site. His principal research interest is the application of patient specific stem cells to build in vitro disease models reflecting disease pathophysiology.
Lars Pedersen (CSO) –
More information: www.bioneer.dk »